Th1 lymphocytes exert an antitumor effect by releasing tumor necrosis factor α (TNF-α), and IFN-γ, while Th2 cells mainly produce interleukin (IL) 4 (IL-4) and thereby promote tumor growth by inhibiting the host’s immune system [1]. This evidence concerns the gene TNF and neoplasm.